ITRM – Iterum Therapeutics Plc
Iterum Therapeutics plcITRM
$1.54Name : Iterum Therapeutics plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $42,374,484.00
EPSttm : -1.76
Iterum Therapeutics plc
$1.54
0.00%$0.0000Float Short %
6.68
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.07
EPS Last/This Y
1.7
EPS This/Next Y
0.21
Price
1.54
Target Price
10
Analyst Recom
1
Performance Q
49.51
Relative Volume
0.18
Beta
2.29
Ticker: ITRM
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | ITRM | 1.76 | N/A | N/A | 0 |
| 2024-12-20 | ITRM | 1.755 | N/A | N/A | 0 |
| 2024-12-23 | ITRM | 1.77 | N/A | N/A | 0 |
| 2024-12-24 | ITRM | 1.74 | N/A | N/A | 0 |
| 2024-12-26 | ITRM | 1.995 | N/A | N/A | 0 |
| 2024-12-27 | ITRM | 1.9 | N/A | N/A | 0 |
| 2024-12-30 | ITRM | 1.79 | N/A | N/A | 0 |
| 2024-12-31 | ITRM | 1.773 | N/A | N/A | 0 |
| 2025-01-02 | ITRM | 1.82 | N/A | N/A | 0 |
| 2025-01-03 | ITRM | 1.925 | N/A | N/A | 0 |
| 2025-01-06 | ITRM | 1.98 | N/A | N/A | 0 |
| 2025-01-07 | ITRM | 1.86 | N/A | N/A | 0 |
| 2025-01-08 | ITRM | 1.79 | N/A | N/A | 0 |
| 2025-01-09 | ITRM | 1.8 | N/A | N/A | 0 |
| 2025-01-10 | ITRM | 1.63 | N/A | N/A | 0 |
| 2025-01-13 | ITRM | 1.635 | N/A | N/A | 0 |
| 2025-01-14 | ITRM | 1.595 | N/A | N/A | 0 |
| 2025-01-15 | ITRM | 1.595 | N/A | N/A | 0 |
| 2025-01-16 | ITRM | 1.54 | N/A | N/A | 0 |
| 2025-01-17 | ITRM | 1.53 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | ITRM | 1.75 | 70.4 | - | -1.03 |
| 2024-12-20 | ITRM | 1.76 | 70.4 | - | -1.03 |
| 2024-12-23 | ITRM | 1.78 | 70.4 | - | -1.03 |
| 2024-12-24 | ITRM | 1.74 | 70.4 | - | -1.03 |
| 2024-12-26 | ITRM | 2.00 | 70.4 | - | -1.03 |
| 2024-12-27 | ITRM | 1.90 | 70.4 | - | -1.03 |
| 2024-12-30 | ITRM | 1.79 | 70.4 | - | -1.03 |
| 2024-12-31 | ITRM | 1.77 | 70.4 | - | -1.03 |
| 2025-01-02 | ITRM | 1.82 | 70.4 | - | -1.03 |
| 2025-01-03 | ITRM | 1.93 | 70.4 | - | -1.03 |
| 2025-01-06 | ITRM | 1.97 | 70.4 | - | -1.03 |
| 2025-01-07 | ITRM | 1.89 | 70.4 | - | -1.03 |
| 2025-01-08 | ITRM | 1.80 | 70.4 | - | -1.03 |
| 2025-01-09 | ITRM | 1.80 | 70.4 | - | -1.03 |
| 2025-01-10 | ITRM | 1.65 | 70.4 | - | -1.03 |
| 2025-01-13 | ITRM | 1.63 | 70.4 | - | -1.03 |
| 2025-01-14 | ITRM | 1.60 | 70.4 | - | -1.03 |
| 2025-01-15 | ITRM | 1.60 | 70.4 | - | -1.03 |
| 2025-01-16 | ITRM | 1.54 | 70.4 | - | -1.03 |
| 2025-01-17 | ITRM | 1.54 | 70.4 | - | -1.03 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | ITRM | 0.00 | 134.86 | 9.42 |
| 2024-12-20 | ITRM | 0.00 | 134.86 | 9.42 |
| 2024-12-23 | ITRM | 0.00 | 134.86 | 9.42 |
| 2024-12-24 | ITRM | 0.00 | 134.86 | 9.42 |
| 2024-12-26 | ITRM | 0.00 | 134.86 | 8.45 |
| 2024-12-27 | ITRM | 0.00 | 134.86 | 8.45 |
| 2024-12-30 | ITRM | 0.00 | 134.83 | 8.45 |
| 2024-12-31 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-02 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-03 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-06 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-07 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-08 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-09 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-10 | ITRM | 0.00 | 134.83 | 8.45 |
| 2025-01-13 | ITRM | 0.00 | 134.83 | 6.68 |
| 2025-01-14 | ITRM | 0.00 | 134.83 | 6.68 |
| 2025-01-15 | ITRM | 0.00 | 134.83 | 6.68 |
| 2025-01-16 | ITRM | 0.00 | 134.83 | 6.68 |
| 2025-01-17 | ITRM | 0.00 | 134.83 | 6.68 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.3
Avg. EPS Est. Current Quarter
-0.24
Avg. EPS Est. Next Quarter
-0.23
Insider Transactions
Institutional Transactions
134.83
Beta
2.29
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
3
Growth Score
20
Sentiment Score
30
Actual DrawDown %
98.2
Max Drawdown 5-Year %
-99
Target Price
10
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-2
Average EPS Est. Cur. Y
-1.03
EPS Next Y. (Est.)
-0.82
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.18
Return on Equity vs Sector %
246.4
Return on Equity vs Industry %
259
EPS 1 7Days Diff
0.6
EPS 1 30Days Diff
0.59
EBIT Estimation
Iterum Therapeutics plcSector: Healthcare
Industry: Biotechnology
Employees: 14
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today
news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance
stock history ITRM – Iterum Therapeutics Plc invest stock market
stock prices ITRM premarket after hours
ticker ITRM fair value insiders trading